BioSpace News Archive

Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that it will release fourth-quarter and full-year 2019 results on Wednesday, February 26th, 2020, after the market closes.

Nautilus, Inc. (NYSE: NLS) today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2019 after the market closes on February 24, 2020, followed by a management hosted conference call to discuss the Company’s operating results.

Feb. 10, 2020 13:30 UTC OncoSec Announces Closing of the CGP/Sirtex Transaction Transaction Provides Immediate Cash Infusion of $30M at Premium to Market Price of $2.50/share SAN DIEGO & PENNINGTON, N.J.--( BUSINESS WIRE )-- OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that, following shareholder approval, the proposed strategic investment by and partnersh

International Isotopes Inc. (OTCQB: INIS) (the “Company”) is pleased to announce it has received approval from the U.S. Food and Drug Administration (FDA) for its SODIUM IODIDE I-131 pharmaceutical product. SODIUM IODIDE I-131 is a radioactive therapeutic agent indicated for the treatment of hyperthyroidism and carcinoma of t

A new study, published in Lancet Digital Health, shows the added value of AI-aided breast cancer detection from mammography images.

Health Canada is advising Canadians that the following products may pose serious health risks.

The Astellas Global Health Foundation (“Foundation”) and the Academic Model Providing Access to Healthcare (AMPATH), under the direction of the Indiana University Center for Global Health, announced today that the Foundation has awarded a $1.35 million grant over three years to AMPATH to provide 400,000 people with access to mental health programming in western Kenya.

QT Ultrasound®, developers of the QTscan®, will be among the innovators in imaging technology to address audiences at some of the most influential industry events kicking off this new year.

Immunovia invites to a teleconference (in English) for investors, analysts and media on Friday, February 14th, 2020 at 8:30 am CET . Immunovia will publish the company’s Full Year 2019 report on February 14 th , 2020 at 8:00 am CET . Mats Grahn , CEO will present Immunovia and comment on the interim report for the period

Depression, relationships and anxiety are the top reasons people text for crisis counseling